(Q33336359)

English

Danaparoid sodium

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

Danaparoid sodium. (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

author name string

J M Acostamadiedo

1

1 reference

Europe PubMed Central

25 July 2017

U G Iyer

2

1 reference

Europe PubMed Central

25 July 2017

J Owen

3

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

25 July 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

25 July 2017

1

1 reference

Europe PubMed Central

25 July 2017

4

1 reference

Europe PubMed Central

25 July 2017

803-814

1 reference

Europe PubMed Central

25 July 2017

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

In vitro study of r-hirudin permeability through membranes of different haemodialysers

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.4.803

21 January 2018

Identifiers

10.1517/14656566.1.4.803

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33336359&oldid=1509398046"